Hickenbottom Sabrina J, Lemke Shawna L, Dueker Stephen R, Lin Yumei, Follett Jennifer R, Carkeet Colleen, Buchholz Bruce A, Vogel John S, Clifford Andrew J
3217A Meyer Hall, Department of Nutrition, University of California, Davis, One Shields Ave, Davis, CA 95616, USA.
Eur J Nutr. 2002 Aug;41(4):141-7. doi: 10.1007/s00394-002-0368-0.
The ability of beta-carotene to deliver bioactive retinoids to tissues is highly variable. A clearer understanding of the environmental and genetic factors that modulate the vitamin A potential of beta-carotene is needed.
Assess the vitamin A value of orally administered beta-carotene relative to a co-administered reference dose of preformed vitamin A.
Equimolar doses (30 micromol) of hexadeuterated D6 beta-carotene and D6 retinyl acetate were orally co-administered in an emulsified formulation to a male subject. The plasma concentration time courses of D6 retinol (derived from D6 retinyl acetate) and bioderived D3 retinol (from D(6) beta-carotene) were determined for 554 h postdosing using gas chromatography/mass spectrometry. Intact D6 beta-carotene plasma concentrations were determined by high-pressure liquid chromatography. The ratio of the two forms of vitamin A, D6 retinol/D3 retinol, at any single time point is postulated to reflect the quantity of vitamin A derived from beta-carotene relative to preformed vitamin A. Additionally, a minute amount of 14C beta-carotene (50 nCi; 0.27 microg) was included in the oral dose and cumulative 24-h stool and urine samples were collected for two weeks to follow absorption and excretion of the b-carotene. The 14C nuclide was detected using accelerator mass spectrometry (AMS). Results During the absorption/distribution phase (3-11 h) the D6/D3 ratio of the two retinols was not stable and ranged between a value of 3 and 16. Between 11 and 98 h postdosing the ratio was relatively stable with a mean value of 8.5 (95 % CI: 7.5, 8.7). These data suggest that in this subject and under these conditions, 8.5 moles of beta-carotene would provide a vitamin A quantity equivalent to 1 mole of preformed vitamin A. On a mass basis, 15.9 microg of beta-carotene was equivalent to 1 microg of retinol. The total administered beta-carotene was found to be 55 % absorbed by AMS analysis of cumulative stool.
The co-administration of D6 beta-carotene and D6 retinyl acetate provides a technique for assessing individual ability to process beta-carotene to vitamin A. The results indicate that a single time point taken between 11-98 h after dose administration may provide a reliable value for the relative ratio of the two forms of vitamin A. However, results from more subjects are needed to assess the general utility of this method.
β-胡萝卜素向组织输送生物活性类视黄醇的能力差异很大。需要更清楚地了解调节β-胡萝卜素维生素A潜力的环境和遗传因素。
评估口服β-胡萝卜素相对于共同给药的预形成维生素A参考剂量的维生素A价值。
将等摩尔剂量(30微摩尔)的十六氘代D6β-胡萝卜素和D6醋酸视黄酯以乳化制剂的形式口服共同给予一名男性受试者。使用气相色谱/质谱法在给药后554小时内测定D6视黄醇(源自D6醋酸视黄酯)和生物衍生的D3视黄醇(来自D(6)β-胡萝卜素)的血浆浓度时间进程。通过高压液相色谱法测定完整的D6β-胡萝卜素血浆浓度。假设在任何单个时间点两种维生素A形式(D6视黄醇/D3视黄醇)的比率反映了源自β-胡萝卜素的维生素A相对于预形成维生素A的量。此外,口服剂量中包含微量的14Cβ-胡萝卜素(50纳居里;0.27微克),并收集两周的累积24小时粪便和尿液样本以追踪β-胡萝卜素的吸收和排泄。使用加速器质谱法(AMS)检测14C核素。结果在吸收/分布阶段(3-11小时),两种视黄醇的D6/D3比率不稳定,范围在3至16之间。给药后11至98小时之间,该比率相对稳定,平均值为8.5(95%置信区间:7.5,8.7)。这些数据表明,在该受试者和这些条件下,8.5摩尔的β-胡萝卜素将提供相当于1摩尔预形成维生素A的维生素A量。以质量计,15.9微克的β-胡萝卜素相当于1微克的视黄醇。通过对累积粪便的AMS分析发现,给予的β-胡萝卜素总量有55%被吸收。
共同给予D6β-胡萝卜素和D6醋酸视黄酯提供了一种评估个体将β-胡萝卜素转化为维生素A能力的技术。结果表明,给药后11-98小时之间的单个时间点可能为两种维生素A形式的相对比率提供可靠值。然而,需要更多受试者的结果来评估该方法的普遍适用性。